Cabazitaxel causes a dose-dependent central nervous system toxicity in rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cabazitaxel causes a dose-dependent central nervous system toxicity in rats

Published:2016-01 Issue: Volume:360 Page:66-71
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Karavelioglu Ergun,Gonul Yucel,Aksit Hasan,Boyaci Mehmet Gazi,Karademir Mustafa,Simsek Nejdet,Guven Mustafa,Atalay Tugay,Rakip Usame

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference26 articles.

1. Neurological adverse effects caused by cytotoxic and targeted therapies;Schiff;Nat. Rev. Clin. Oncol.,2009

2. Central and peripheral nervous system toxicity of common chemotherapeutic agents;Sioka;Cancer Chemother. Pharmacol.,2009

3. Cabazitaxel in patients with advanced solid tumours: results of a phase I and pharmacokinetic study;Dieras;Eur. J. Cancer,2013

4. Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every 3weeks in patients with advanced solid tumors;Mita;Clin. Cancer Res.,2009

5. A multicenter phase II study of XRP6258 administered as a 1-h iv infusion every 3weeks in taxane-resistant metastatic breast cancer patients;Pivot;Ann. Oncol.,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cetuximab decorated redox sensitive D-alpha-tocopheryl- polyethyleneglycol-1000-succinate based nanoparticles for cabazitaxel delivery: Formulation, lung targeting and enhanced anti-cancer effects;International Journal of Pharmaceutics;2024-03

2. Calotropis procera extract inhibits prostate cancer through regulation of autophagy;Journal of Cellular and Molecular Medicine;2024-02-23

3. Inhibition of necroptosis mitigates paclitaxel-induced neuronal damage and cognitive impairment;2024-01-09

4. Central Neurotoxicity of Chemotherapy;Handbook of Cancer and Immunology;2023

5. Central Neurotoxicity of Chemotherapy;Handbook of Cancer and Immunology;2022-12-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3